Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
phentermine hydrochloride, Quantity: 49.79 mg (Equivalent: phentermine, Qty 40 mg)
Aspen Pharmacare Australia Pty Ltd
Capsule, modified release
Excipient Ingredients: lactose monohydrate; sodium polystyrene sulfonate; magnesium stearate; liquid paraffin; titanium dioxide; purified water; sunset yellow FCF; erythrosine; Gelatin; iron oxide black; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; Shellac; sulfuric acid
Oral
30
(S4) Prescription Only Medicine
ALENAMI is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (BMI) of 30 kg/m2 or greater. The treatment with ALENAMI can be initiated in overweight patients with a lower BMI (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. Secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.
Visual Identification: HGC size 3 gelatine capsule with opaque orange and grey body and cap, both inscribed 40 in black ink. Containing a mixture of white powder and brilliant brown spherical beads.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2021-02-25
ASPEN ADRENALINE Injection - CMI Page 1 of 4 ALENAMI TM CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ALENAMI. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. If you need any more information about ALENAMI please ask your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of you taking ALENAMI against the benefits it can have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again WHAT ALENAMI CAPSULES IS USED FOR The name of your medicine is ALENAMI. ALENAMI capsules contain the active ingredient, phentermine. Phentermine is combined with a resin which slowly releases the phentermine so the effect of ALENAMI lasts all day. ALENAMI is used to reduce body weight in obese or overweight patients. Your doctor will assess whether ALENAMI is suitable for you. ALENAMI works by directly affecting the area of the brain that controls your appetite making you feel less hungry. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. ALENAMI should be used as a part of an overall weight management plan which should include a medically controlled diet and exercise program. ALENAMI is available only with a doctor's prescription. Your doctor may prescribe ALENAMI for another purpose. If you are not sure why you are taking this medicine ask your doctor. BEFORE YOU ARE GIVEN IT _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE ALENAMI IF YOU HAVE AN ALLERGY TO: • any medicine containing phentermine • any of the ingredients listed at the end of this leaflet • any other similar medicines used to reduce weight Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue, or other parts of the body • rash, itching or hives on Przeczytaj cały dokument
1 AUSTRALIAN PRODUCT INFORMATION – ALENAMI ( PHENTERMINE ) 1 NAME OF THE MEDICINE Phentermine 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ALENAMI capsule contains phentermine as an ion-exchange resin complex equivalent to 15, 30 or 40 mg phentermine depending on strength. ‘For the full list of excipients, see Section 6.1 List of excipients’. ALENAMI capsules are gluten-free_. _ 3 PHARMACEUTICAL FORM ALENAMI phentermine capsules are modified release capsules and are supplied in 3 strengths as described below: ALENAMI phentermine 15mg capsule blister pack are hard gelatin capsules (pale green opaque cap/grey opaque body, marked 15 in black ink) ALENAMI phentermine 30mg capsule blister pack are hard gelatin capsules (reddish/brown opaque cap/grey opaque body, marked 30 in black ink) ALENAMI phentermine 40mg capsule blister pack are hard gelatin capsules (orange opaque cap/grey opaque body, marked 40 in black ink) The ion-exchange resin is quite stable, highly insoluble and without pharmacological effect until it reacts with cations (hydrogen, potassium, sodium etc.) present in the gastrointestinal fluids. Phentermine is then released from the resin complex at a rate dependent on the total concentration of these cations. Since this concentration is fairly constant throughout the entire gastrointestinal tract, continuous and controlled ionic release occurs over a 10 to 14 hour period. 2 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS ALENAMI is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (BMI) of 30 kg/m 2 or greater. The treatment with ALENAMI can be initiated in overweight patients with a lower BMI (25 to 29.9 kg/m 2 ), which increases the risk of morbidity from a number of disorders. Secondary organic causes of obesity should be excluded by diagnosis before presc Przeczytaj cały dokument